Search
Now showing items 31-38 of 38
Methods and constructs for producing transgenic plants and methods of recovering expressed proteins
(United States. Patent and Trademark Office, 2012-08-28)
This invention relates to a regulatory element useful for genetically engineering sugarcane or other monocots, to the transformation of the monocots with the regulatory element so that they produce a desired product, and ...
Decorin binding protein compositions and methods of use
(United States. Patent and Trademark Office, 1998-12-29)
Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
HSP20 inhibits amyloidogenesis and neurotoxicity
(United States. Patent and Trademark Office, 2017-10-31)
The present invention compositions and methods of using at least a portions of an isolated and purified α-crystallin polypeptide that includes one or more β-pleated sheets and that prevents neurotoxicity and amyloidogenesis.
Modified lantibiotics and methods of making and using the modified lantibiotics
(United States. Patent and Trademark Office, 2020-03-03)
The subject invention pertains to a modified lantibiotic containing an intact cysteine at the C-terminus, particularly, a cysteine that is not decarboxylated and that contains a free carboxyl group. Derivatives of the ...
Modified lantibiotics and methods of making and using the modified lantibiotics
(United States. Patent and Trademark Office, 2022-01-18)
The subject invention pertains to a modified lantibiotic containing an intact cysteine at the C-terminus, particularly, a cysteine that is not decarboxylated and that contains a free carboxyl group. Derivatives of the ...
Fusion Proteins (Seldegs) For Selectively Depleting Antigen-specific Antibodies And Methods Of Use Thereof
(United States. Patent and Trademark Office, 10/4/2022)
The present disclosure includes a fusion protein, called a "Seldeg", including a targeting component that specifically binds to a cell surface receptor or other cell surface molecule at near-neutral pH, and an antigen ...
Modulators Of Melanocortin Receptors For The Treatment Of Depression And Anxiety
(United States. Patent and Trademark Office, 1/3/2023)
Compositions and methods for treating a depressive disorder or an anxiety disorder in a subject in need of such treatment are described herein. A therapeutically effective amount of a composition comprising a melanocortin ...
Crystal structure of Staphylococcus aureus clumping factor A in complex with fibrinogen derived peptide and uses thereof
(United States. Patent and Trademark Office, 2021-06-22)
The present invention discloses crystal structure of Staphylococcus aureus Clumping factor A (ClfA) in complex with fibrinogen (Fg) derived peptide. Also, the present invention also discloses the use of this structure in ...